Hong Bin Zhou

Hong Bin Zhou currently works at Legend Capital Co. Ltd., as Co-Chief Investment Officer & Managing Director from 2005, MicuRx Pharmaceuticals, Inc., as Director from 2020, Milkyway Intelligent Supply Chain Service Group Co., Ltd., as Director from 2015, Shanghai Cell Therapy Group Co., Ltd., as Director from 2016, Jiangsu Recbio Technology Co., Ltd., as Non-Executive Director from 2021, Shanghai Atour Business Management Group Co., Ltd., as Director from 2017, Joy Wing Mau Corp.
Ltd., as Director from 2019, Atour Lifestyle Holdings Ltd., as Director, Ningbo Xinwan Technology Development Co. Ltd., as Director from 2017, and China Southern Airlines Cargo Logistics Guangzhou Co. Ltd., as Director from 2021.
Dr. Zhou also formerly worked at Shanghai Genext Medical Technology Co., Ltd., as Chairman-Supervisory Board, Pharmaron Beijing Co., Ltd., as Non-Executive Director from 2020 to 2023, Jiangsu Lihua Animal Husbandry Co., Ltd., as Director, Chemclin Diagnostics Co., Ltd., as Director from 2018 to 2023, Shanghai MicuRx Pharmaceutical Co., Ltd., as Director, and Guangzhou Kingmed Diagnostics Group Co., Ltd., as Member-Supervisory Board.
Dr. Zhou received his graduate degree in 1997 from Wuhan University, undergraduate degree in 1994 from Wuhan University, and doctorate degree in 2000 from Fudan University.